NSE: EMAMILTD | BSE: 531162

Mid-range Performer

Download real time

540.60 -1.80 (-0.33%)

27.57% Fall from 52W High

112.5K NSE+BSE Volume

NSE 13 Oct, 2025 11:50 AM (IST)

23,597.2

Market Cap

Below industry Median

0.7

Beta 1Year

Very Low volatility

Emami Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for EMAMILTD, BSE:531162 Emami Ltd.

Emami Ltd.

08 Aug 2023

540.60

-0.33%

Some tailwinds and many execution improvements

Accumulate: Emami Ltd.

Target

ICICI Securities Limited

Emami reported robust double-digit growth (+16% YoY) in non-summer portfolio, while summer portfolio was impacted by unseasonal rains in key markets. Growth was driven by the return of double-digit growth in pain management and healthcare range which is encouraging. Scale-up of Dermicool (+9% YoY) is also progressing well with the launch of new campaign and LUP SKUs to induce consumer trials.

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

08 Aug 2023

540.60

-0.33%

In-line performance; margin improving

Buy: Emami Ltd.

Target

Motilal Oswal

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

26 May 2023

540.60

-0.33%

Weak performance continues across the board

Accumulate: Emami Ltd.

Target

ICICI Securities Limited

Emami reported a patchy revenue performance with (consol.) adjusted revenue (explained below) decline of ~2% YoY. Weak performance was due to subdued rural demand (some green shoots in current quarter) and unseasonal rains.

Emami Ltd. is trading below all available SMAs

Emami Ltd.

25 May 2023

540.60

-0.33%

EMAMI LTD

Accumulate: Emami Ltd.

Target

Prabhudas Lilladhar

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

06 Feb 2023

540.60

-0.33%

Weak performance across the board

Accumulate: Emami Ltd.

ICICI Securities Limited

Emami reported a patchy revenue performance with (consol.) revenue growth of 1%; adjusted revenue growth YoY (explained below) declined ~4% YoY. Weak performance was due to subdued rural demand (no signs of revival; Jan continues to be weak),